169 related articles for article (PubMed ID: 24983324)
1. Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemia.
Alsagaby SA; Khanna S; Hart KW; Pratt G; Fegan C; Pepper C; Brewis IA; Brennan P
J Proteome Res; 2014 Nov; 13(11):5051-62. PubMed ID: 24983324
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
3. Improved reporter ion assignment of raw isobaric stable isotope labeled liquid chromatography/matrix-assisted laser desorption/ionization tandem time-of-flight mass spectral data for quantitative proteomics.
Jakoby T; Tholey A; van den Berg BH
Rapid Commun Mass Spectrom; 2012 Dec; 26(23):2777-85. PubMed ID: 23124669
[TBL] [Abstract][Full Text] [Related]
4. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
[TBL] [Abstract][Full Text] [Related]
5. Protein profiles distinguish stable and progressive chronic lymphocytic leukemia.
Huang PY; Mactier S; Armacki N; Giles Best O; Belov L; Kaufman KL; Pascovici D; Mulligan SP; Christopherson RI
Leuk Lymphoma; 2016 May; 57(5):1033-43. PubMed ID: 26422656
[TBL] [Abstract][Full Text] [Related]
6. Multipronged functional proteomics approaches for global identification of altered cell signalling pathways in B-cell chronic lymphocytic leukaemia.
Díez P; Lorenzo S; Dégano RM; Ibarrola N; González-González M; Nieto W; Almeida J; González M; Orfao A; Fuentes M
Proteomics; 2016 Apr; 16(8):1193-203. PubMed ID: 26910488
[TBL] [Abstract][Full Text] [Related]
7. Chronically inflamed synovium from spondyloarthropathy and rheumatoid arthritis investigated by protein expression profiling followed by tandem mass spectrometry.
Tilleman K; Van Beneden K; Dhondt A; Hoffman I; De Keyser F; Veys E; Elewaut D; Deforce D
Proteomics; 2005 May; 5(8):2247-57. PubMed ID: 15846842
[TBL] [Abstract][Full Text] [Related]
8. GALNT11 as a new molecular marker in chronic lymphocytic leukemia.
Libisch MG; Casás M; Chiribao M; Moreno P; Cayota A; Osinaga E; Oppezzo P; Robello C
Gene; 2014 Jan; 533(1):270-9. PubMed ID: 24076351
[TBL] [Abstract][Full Text] [Related]
9. MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.
Oh JH; Pan S; Zhang J; Gao J
Rapid Commun Mass Spectrom; 2010 Feb; 24(4):403-8. PubMed ID: 20069694
[TBL] [Abstract][Full Text] [Related]
10. A strategy for high-resolution protein identification in surface-enhanced laser desorption/ionization mass spectrometry: calgranulin A and chaperonin 10 as protein markers for endometrial carcinoma.
Guo J; Yang EC; Desouza L; Diehl G; Rodrigues MJ; Romaschin AD; Colgan TJ; Siu KW
Proteomics; 2005 May; 5(7):1953-66. PubMed ID: 15816004
[TBL] [Abstract][Full Text] [Related]
11. Identification of biomarkers indicating cellular changes after treatment of neuronal cells with the C3 exoenzyme from Clostridium botulinum using the iTRAQ protocol and LC-MS/MS analysis.
Muetzelburg MV; Hofmann F; Just I; Pich A
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1344-51. PubMed ID: 19109081
[TBL] [Abstract][Full Text] [Related]
12. Protein- versus peptide fractionation in the first dimension of two-dimensional high-performance liquid chromatography-matrix-assisted laser desorption/ionization tandem mass spectrometry for qualitative proteome analysis of tissue samples.
Melchior K; Tholey A; Heisel S; Keller A; Lenhof HP; Meese E; Huber CG
J Chromatogr A; 2010 Oct; 1217(40):6159-68. PubMed ID: 20810122
[TBL] [Abstract][Full Text] [Related]
13. Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation.
Rodríguez A; Villuendas R; Yáñez L; Gómez ME; Díaz R; Pollán M; Hernández N; de la Cueva P; Marín MC; Swat A; Ruiz E; Cuadrado MA; Conde E; Lombardía L; Cifuentes F; Gonzalez M; García-Marco JA; Piris MA;
Leukemia; 2007 Sep; 21(9):1984-91. PubMed ID: 17611561
[TBL] [Abstract][Full Text] [Related]
14. Identification of proteomic signatures of mantle cell lymphoma, small lymphocytic lymphoma, and marginal zone lymphoma biopsies by surface enhanced laser desorption/ionization-time of flight mass spectrometry.
Rolland D; Bouamrani A; Houlgatte R; Barbarat A; Ramus C; Arlotto M; Ballester B; Berger F; Felman P; Callet-Bauchu E; Baseggio L; Traverse-Glehen A; Brugière S; Garin J; Coiffier B; Berger F; Thieblemont C
Leuk Lymphoma; 2011 Apr; 52(4):648-58. PubMed ID: 21438832
[TBL] [Abstract][Full Text] [Related]
15. Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment.
Admoni-Elisha L; Nakdimon I; Shteinfer A; Prezma T; Arif T; Arbel N; Melkov A; Zelichov O; Levi I; Shoshan-Barmatz V
PLoS One; 2016; 11(4):e0148500. PubMed ID: 27078856
[TBL] [Abstract][Full Text] [Related]
16. Phosphopeptide quantitation using amine-reactive isobaric tagging reagents and tandem mass spectrometry: application to proteins isolated by gel electrophoresis.
Sachon E; Mohammed S; Bache N; Jensen ON
Rapid Commun Mass Spectrom; 2006; 20(7):1127-34. PubMed ID: 16521170
[TBL] [Abstract][Full Text] [Related]
17. A new calibrant for matrix-assisted laser desorption/ionization time-of-flight-time-of-flight post-source decay tandem mass spectrometry of non-digested proteins for top-down proteomic analysis.
Fagerquist CK; Sultan O
Rapid Commun Mass Spectrom; 2012 May; 26(10):1241-8. PubMed ID: 22499200
[TBL] [Abstract][Full Text] [Related]
18. Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.
Del Giudice I; Chiaretti S; Santangelo S; Tavolaro S; Peragine N; Marinelli M; Ilari C; Raponi S; Messina M; Nanni M; Mauro FR; Piciocchi A; Bontempi K; Rossi D; Gaidano G; Guarini A; Foà R
Am J Hematol; 2014 Jan; 89(1):74-82. PubMed ID: 24030933
[TBL] [Abstract][Full Text] [Related]
19. ATM, CTLA4, MNDA, and HEM1 in high versus low CD38 expressing B-cell chronic lymphocytic leukemia.
Joshi AD; Hegde GV; Dickinson JD; Mittal AK; Lynch JC; Eudy JD; Armitage JO; Bierman PJ; Bociek RG; Devetten MP; Vose JM; Joshi SS
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5295-304. PubMed ID: 17875758
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
